يعرض 1 - 10 نتائج من 20 نتيجة بحث عن '"Chorionic Gonadotropin/analysis"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المؤلفون: Reinauer, H, Wood, WG

    المصدر: GMS German Medical Science; VOL: 3; DOC02 /20050530/

    العلاقة: Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68(5):1331-7.; Berson SA, Yalow RS. Radioimmunoassay of ACTH in plasma. J Clin Invest 1968;47(12):2725-51.; Bloomfield GA, Holdaway IM, Corrin B, Ratcliffe JG, Rees GM, Ellison M, Rees LH. Lung tumours and ACTH production. Clin Endocrinol (Oxf). 1977;6(2):95-104.; Bodenmüller H, Ofenloch-Hähnle B, Lane EB, Dessauer A, Böttger V, Donie F. Lung cancer-associated keratin 19 fragments:development and biochemical characterisation of the new serum assay Enzymun-Test CYFRA 21-1. Int J Biol Markers. 1994;9(2):75-81; Brawer MK. Prostate-specific antigen: current status. CA Cancer J Clin. 1999;49(5):264-81.; Bundesärztekammer. Richtlinie der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen. Gemäß Beschluss des Vorstandes der Bundesärztekammer vom 24. August 2001, veröffentlicht im Deutschen Ärzteblatt 98, Heft 42, 19. Oktober 2001, Seite A 2747 - 2759. Zuletzt geändert durch Beschluss des Vorstandes der Bundesärztekammer vom 14. November 2003, veröffentlicht im Deutschen Ärzteblatt 100, Heft 50, 12. Dezember 2003, Seite A 3335 - 3338. Dtsch Ärztebl. 2003;100(50):A3335-A3338. Available from: http://www.bundesaerztekammer.de/30/Richtlinien/Richtidx/Labor2002/RiliLabor.pdfTest; Charters AC, Odell WD, Thompson JC. Anterior pituitary function during surgical stress and convalescence. Radioimmunoassay measurement of blood TSH, LH, FSH and growth hormone. J Clin Endocrinol Metab. 1969;29(1):63-71.; Cornelisse CJ, Cornelis RS, Devilee P. Genes responsible for familial breast cancer. Pathol Res Pract. 1996;192(7):684-93.; Del Villano BC, Zurawski VR Jr. The carbohydrate antigenic determinant 19-9 (CA 19-9):a monoclonal antibody defined tumor marker. Lab Res Methods Biol Med. 1983;8:269-82.; Duffy MJ. Evidence for the clinical use of tumour markers. Ann Clin Biochem. 2004;41(Pt 5):370-7.; Feldman JM. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors. Gastroenterology. 1978;75(6):1109-14.; Gang Y, Adachi I, Ohkura H, Yamamoto H, Mizuguchi Y, Abe K. CA 15-3 is present as a novel tumour marker in the sera of patients with breast cancer and other malignancies. Gan To Kagaku Ryoho. 1985;12(12):2379-86.; Gold P, Freedman SO. Demonstration of tumor specific antigens in human colonic carcinoma by immunologic tolerance and absorption technique. J Exp Med. 1965;121:439-62.; Hall JM, Freedman L, Guenther C, Lee MK, Weber JL, Black DM, King MC. Closing in on a breast cancer gene on chromosome 17q. Amer J Hum Genet. 1992;50(6):1235-42.; Herrero-Zabaleta ME, Gautier R, Burtin P, Daher N, Bara J. Monoclonal antibody against sialylated Lewis(a) antigen. Bull Cancer. 1987;74(4):387-96.; Hirohashi S, Shimosato Y, Ino Y, Tome Y, Watanabe M, Hirota T, Itabashi M. Distribution of blood group antigens and CA 19-9 in gastric cancers and non-neoplastic gastric mucosa. Gann. 1984;75(6):540-7.; Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Eng J Med. 2004;351(6):533-42.; Huggins C, Hodges CV. Studies on prostatic cancer. The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1:293-7.; Inazawa J, Inoue J, Imoto I. Comparative genomic hybridisation (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci. 2004;95(7):559-63.; Krupey J, Gold P, Freedman SO:Physicochemical studies of the carcinoembryonic antigens of the human digestive system. J Exp Med. 1968;128(3):387-98.; Lamerz R. PSA (Prostata-spezifisches Anitigen). In: Thomas L, ed. Labor und Diagnose. 5. ed. Frankfurt/Main: TH-Books Verlagsgesellschaft; 1998. p. 1004-8 (Kap. 34.14).; Midgley AR Jr, Niswender GD, Ram JS. Hapten-radioimmunoassay: a general procedure for the estimation of steroidal and other haptenic substances. Steroids 1969;13(6):731-7.; Mitrunen K, Pettersson K, Piironen T, Bjork T, Lilja H, Lövgren T. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clin Chem. 1995;41(8 Pt 1):1115-20.; Morrison C, Farrar W, Kneile J, Williams N, Liu-Stratton Y, Bakaletz A, Aldred MA, Eng C. Molecular classification of parathyroid neoplasia by gene expression profiling. Am J Pathol. 2004;165(2):565-76.; Murphy BE. Radioassays of non-antigenic hormones. Trans Assoc Am Physicians. 1968;81:92-103.; Mutter GL, Baak JP, Fitzgerald JT, Gray R, Neuberg D, Kust GA, Gentleman R, Gullans SR, Wei LJ, Wilcox M. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol. 2001;83(2):177-85.; Ohuchi N, Takahashi K, Matoba N, Mori S. A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4. Gan To Kagaku Ryoho. 1988;15(9):2761-6.; Pour PM, Tempero MM, Takasaki H, Uchida E, Takiyama Y, Burnett DA, Steplewski Z. Expression of blood group related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res. 1988;48(19):5422-6.; Rushworth AG, Orr AH, Bagshawe KD. The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system. Br J Cancer. 1968;22(2):253-7.; Schutte M, Rozenblum E, Moskaluk CA, Guan X, Hoque AT, Hahn SA, da Costa LT, de Jong PJ, Kern SE. An integrated high-resolution physical map of the DPC/BRCA2 region at chromosome 13q12. Cancer Res. 1995;55(29):4570-4.; Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol. 2004;172(4 Pt 1):1297-301.; Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer:assay of the complex improves clinical sensitivity for cancer. Cancer Res. 1991;51(1):222-6.; Stieber P, Thomas L, Lamerz R, Raue F, Grauer A, Nollau P et al. Tumormarker (Kapitel 28). In: Thomas L, ed. Labor und Diagnose - Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik. 6. Aufl. Frankfurt/Main: TH-Books Verlagsgesellschaft mbH; 2005. p. 1291-1366.; Tashjian AH Jr, Melvin EW. Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts. N Eng J Med. 1968;279(6):279-83.; Thomas L, Lüthgens M, Wagener C, Lamerz R, Mann K, Tatra G et al. Tumormarker. In: Thomas L, ed. Labor und Diagnose - Indikation und Bewertung von Laborbefunden in die medizinische Diagnostik. 3., überarb. u. erw. Aufl. Marburg: Med. Verlagsgesellschaft; 1988. p. 945-1015.; Turler K, Kaser H. Quantitative fluorimetric determination of urinary dopa and its significance for the diagnosis of neural crest tumours. Clin Chim Acta. 1971;32(1):41-51.; Van Niekerk CC, Boerman OC, Ramaekers FC, Poels LG. Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas. Am J Pathol. 1991;138(2):455-63.; Vessella RL, Lange PH. Issues in the assessment of PSA immunoassays. Urol Clin North Am. 1993;20(4):607-19.; von Euler U, Lishajko F. Improved technique for the fluorimetric estimation of catecholamines. Acta Physiol Scand. 1961;51:348-55.; Whipple ME, Mendez E, Farwell DG, Agoff SN, Chen C. A genomic predictor of oral squamous cell carcinoma. Laryngoscope. 2004;114(8):1346-54.; Wood WG, Steinhoff J, Kessler AC. Anomalous tumour marker concentrations in renal transplant patients. Eur J Clin Chem Clin Biochem. 1993;31(2):75-82.; Wood WG, van der Sloot E, Böhle A. The establishment and evaluation of luminescent-labelled immunometric assays for prostate-specific antigen-alpha 1-antichymotrypsin complexes in serum. Eur J Clin Chem Clin Biochem. 1991;29(12):787-94.; Wood WG, Steinhoff J, Gutekunst R. Sense and nonsense in determination of tumour markers in serum - results with potentially disastrous consequences. In: Klapdor R, ed. Tumor associated antigens, oncogenes, receptors, cytokines in tumor diagnosis and therapy at the beginning of the nineties. München: Zuckschwerdt; 1992. p. 305-12.; Wood WG, Mainwaring-Burton RW. The development and evaluation of a semi-automated assay for catecholamines suitable for plasma and urine. Clin Chim Acta. 1975;61(3):297-308.; Wu JT, Wilson LW. Development of a microplate ELISA for free PSA and PSA-ACT complex in serum. J Clin Lab Anal 1995;9(4):252-60.; http://www.egms.de/en/journals/gms/2005-3/000020.shtmlTest

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5

    المؤلفون: Reinauer, H, Wood, WG

    المصدر: GMS German Medical Science; VOL: 3; DOC02 /20050530/

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    مراجعة
  10. 10
    دورية أكاديمية